409 related articles for article (PubMed ID: 16809290)
1. Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry.
Ghez D; Lepelletier Y; Lambert S; Fourneau JM; Blot V; Janvier S; Arnulf B; van Endert PM; Heveker N; Pique C; Hermine O
J Virol; 2006 Jul; 80(14):6844-54. PubMed ID: 16809290
[TBL] [Abstract][Full Text] [Related]
2. Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells.
Jones KS; Fugo K; Petrow-Sadowski C; Huang Y; Bertolette DC; Lisinski I; Cushman SW; Jacobson S; Ruscetti FW
J Virol; 2006 Sep; 80(17):8291-302. PubMed ID: 16912281
[TBL] [Abstract][Full Text] [Related]
3. Syncytium formation by recombinant HTLV-II envelope glycoprotein.
Li QX; Camerini D; Xie Y; Greenwald M; Kuritzkes DR; Chen IS
Virology; 1996 Apr; 218(1):279-84. PubMed ID: 8615036
[TBL] [Abstract][Full Text] [Related]
4. Human Dlg protein binds to the envelope glycoproteins of human T-cell leukemia virus type 1 and regulates envelope mediated cell-cell fusion in T lymphocytes.
Blot V; Delamarre L; Perugi F; Pham D; Bénichou S; Benarous R; Hanada T; Chishti AH; Dokhélar MC; Pique C
J Cell Sci; 2004 Aug; 117(Pt 17):3983-93. PubMed ID: 15286176
[TBL] [Abstract][Full Text] [Related]
5. A novel neuropilin-1-binding sequence in the human T-cell lymphotropic virus type 1 envelope glycoprotein.
Kusunoki H; Tanaka T; Kohno T; Matsuhashi K; Hosoda K; Wakamatsu K; Hamaguchi I
Biochim Biophys Acta Proteins Proteom; 2018 Apr; 1866(4):541-548. PubMed ID: 29458191
[TBL] [Abstract][Full Text] [Related]
6. Interaction of CD82 tetraspanin proteins with HTLV-1 envelope glycoproteins inhibits cell-to-cell fusion and virus transmission.
Pique C; Lagaudrière-Gesbert C; Delamarre L; Rosenberg AR; Conjeaud H; Dokhélar MC
Virology; 2000 Oct; 276(2):455-65. PubMed ID: 11040136
[TBL] [Abstract][Full Text] [Related]
7. Molecular aspects of HTLV-1 entry: functional domains of the HTLV-1 surface subunit (SU) and their relationships to the entry receptors.
Jones KS; Lambert S; Bouttier M; Bénit L; Ruscetti FW; Hermine O; Pique C
Viruses; 2011 Jun; 3(6):794-810. PubMed ID: 21994754
[TBL] [Abstract][Full Text] [Related]
8. HTLV-1 and -2 envelope SU subdomains and critical determinants in receptor binding.
Kim FJ; Manel N; Garrido EN; Valle C; Sitbon M; Battini JL
Retrovirology; 2004 Dec; 1():41. PubMed ID: 15575958
[TBL] [Abstract][Full Text] [Related]
9. Heat shock cognate protein 70 is a cell fusion-enhancing factor but not an entry factor for human T-cell lymphotropic virus type I.
Fang D; Haraguchi Y; Jinno A; Soda Y; Shimizu N; Hoshino H
Biochem Biophys Res Commun; 1999 Aug; 261(2):357-63. PubMed ID: 10425190
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of synapse-associated protein Dlg1 reduces syncytium formation induced by human T-cell leukemia virus type 1.
Yoshida S; Higuchi M; Shoji T; Yoshita M; Ishioka K; Takahashi M; Oie M; Tanaka Y; Uchiyama M; Fujii M
Virus Genes; 2008 Aug; 37(1):9-15. PubMed ID: 18461433
[TBL] [Abstract][Full Text] [Related]
11. Alternate receptor usage of neuropilin-1 and glucose transporter protein 1 by the human T cell leukemia virus type 1.
Jin Q; Alkhatib B; Cornetta K; Alkhatib G
Virology; 2010 Jan; 396(2):203-12. PubMed ID: 19913864
[TBL] [Abstract][Full Text] [Related]
12. The HTLV receptor is a widely expressed protein.
Trejo SR; Ratner L
Virology; 2000 Mar; 268(1):41-8. PubMed ID: 10683325
[TBL] [Abstract][Full Text] [Related]
13. Host range of human T-cell leukemia virus type I analyzed by a cell fusion-dependent reporter gene activation assay.
Okuma K; Nakamura M; Nakano S; Niho Y; Matsuura Y
Virology; 1999 Feb; 254(2):235-44. PubMed ID: 9986790
[TBL] [Abstract][Full Text] [Related]
14. Interaction between the HTLV-1 envelope and cellular proteins: impact on virus infection and restriction.
Ilinskaya A; Heidecker G; Jones K
Future Med Chem; 2010 Nov; 2(11):1651-68. PubMed ID: 21428837
[TBL] [Abstract][Full Text] [Related]
15. The N93D mutation of the human T-cell leukemia virus type 1 envelope glycoprotein found in symptomatic patients enhances neuropilin-1 b1 domain binding.
Kusunoki H; Tanaka T; Ohshima C; Sakamoto T; Wakamatsu K; Hamaguchi I
Biochim Biophys Acta Proteins Proteom; 2021 Nov; 1869(11):140708. PubMed ID: 34343702
[TBL] [Abstract][Full Text] [Related]
16. Separate cellular localizations of human T-lymphotropic virus 1 (HTLV-1) Env and glucose transporter type 1 (GLUT1) are required for HTLV-1 Env-mediated fusion and infection.
Maeda Y; Terasawa H; Tanaka Y; Mitsuura C; Nakashima K; Yusa K; Harada S
J Virol; 2015 Jan; 89(1):502-11. PubMed ID: 25339765
[TBL] [Abstract][Full Text] [Related]
17. HTLV envelopes and their receptor GLUT1, the ubiquitous glucose transporter: a new vision on HTLV infection?
Manel N; Taylor N; Kinet S; Kim FJ; Swainson L; Lavanya M; Battini JL; Sitbon M
Front Biosci; 2004 Sep; 9():3218-41. PubMed ID: 15353351
[TBL] [Abstract][Full Text] [Related]
18. Control of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Infection by Eliminating Envelope Protein-Positive Cells with Recombinant Vesicular Stomatitis Viruses Encoding HTLV-1 Primary Receptor.
Tezuka K; Okuma K; Kuramitsu M; Matsuoka S; Tanaka R; Tanaka Y; Hamaguchi I
J Virol; 2018 Feb; 92(4):. PubMed ID: 29212930
[TBL] [Abstract][Full Text] [Related]
19. Isolated receptor binding domains of HTLV-1 and HTLV-2 envelopes bind Glut-1 on activated CD4+ and CD8+ T cells.
Kinet S; Swainson L; Lavanya M; Mongellaz C; Montel-Hagen A; Craveiro M; Manel N; Battini JL; Sitbon M; Taylor N
Retrovirology; 2007 May; 4():31. PubMed ID: 17504522
[TBL] [Abstract][Full Text] [Related]
20. HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165.
Lambert S; Bouttier M; Vassy R; Seigneuret M; Petrow-Sadowski C; Janvier S; Heveker N; Ruscetti FW; Perret G; Jones KS; Pique C
Blood; 2009 May; 113(21):5176-85. PubMed ID: 19270265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
